[HTML][HTML] Prescribed drugs containing nitrogen heterocycles: an overview

MM Heravi, V Zadsirjan - RSC advances, 2020 - pubs.rsc.org
Heteroatoms as well as heterocyclic scaffolds are frequently present as the common cores in
a plethora of active pharmaceuticals natural products. Statistically, more than 85% of all …

[HTML][HTML] Thinking outside the bug: molecular targets and strategies to overcome antibiotic resistance

A Monserrat-Martinez, Y Gambin… - International journal of …, 2019 - mdpi.com
Since their discovery in the early 20th century, antibiotics have been used as the primary
weapon against bacterial infections. Due to their prophylactic effect, they are also used as …

Fluorine in health care: Organofluorine containing blockbuster drugs

D O'Hagan - Journal of Fluorine Chemistry, 2010 - Elsevier
Organic fluorine compounds have had a profound impact on the development of bioactives
for the modern pharmaceuticals market. It is estimated that up to 20% of pharmaceuticals …

In-situ growth of Mn2O3/MnCo2O4 on 3D nickel foam as a novel heterogeneous composites peroxymonosulfate activator for the degradation of levofloxacin …

L Song, X Cheng, Y Yang, Y Hou, X Gan… - Chemical Engineering …, 2023 - Elsevier
The in-situ generation of nanostructured materials on the metal-based carriers nickel foam
(NF) is a novel technique for water remediation materials. In this study, Mn 2 O 3/MnCo 2 O 4 …

The safety profile of the fluoroquinolones

J Bertino Jr, D Fish - Clinical therapeutics, 2000 - Elsevier
BACKGROUND: Premarketing trials showed the fluoroquinolone agents to have a favorable
side-effect profile, with treatment-related adverse events comprising gastrointestinal, central …

The 2‐pyridone antibacterial agents: bacterial topoisomerase inhibitors

Q Li, LA Mitscher, LL Shen - Medicinal research reviews, 2000 - Wiley Online Library
Many attempts have been made to prepare analogs of 4‐quinolone antibacterial agents
bearing novel ring systems, which might retain the favorable properties of these widely used …

[HTML][HTML] Comparative activity of ciprofloxacin, levofloxacin and moxifloxacin against Klebsiella pneumoniae, Pseudomonas aeruginosa and Stenotrophomonas …

A Grillon, F Schramm, M Kleinberg, F Jehl - PloS one, 2016 - journals.plos.org
The aim of this study was to compare the in vitro susceptibility of Klebsiella pneumoniae,
Pseudomonas aeruginosa and Stenotrophomonas maltophilia to three fluoroquinolones …

Smart lipid nanoparticles containing levofloxacin and DNase for lung delivery. Design and characterization

GA Islan, PC Tornello, GA Abraham, N Duran… - Colloids and Surfaces B …, 2016 - Elsevier
Levofloxacin (LV) is a hydrophilic broad-spectrum antibiotic commonly used in pulmonary
treatment against recurrent infections of Pseudomonas aeruginosa, and particularly in cystic …

Fluoroquinolone adverse effects and drug interactions

DN Fish - … : The Journal of Human Pharmacology and Drug …, 2001 - Wiley Online Library
Extensive pharmacologic and clinical development of quinolone antimicrobial agents has
resulted in improved antimicrobial activity, pharmacokinetic features, toxicity, and drug‐drug …

Comparative pharmacokinetics and pharmacodynamics of the newer fluoroquinolone antibacterials

A Aminimanizani, P Beringer, R Jelliffe - Clinical pharmacokinetics, 2001 - Springer
A number of new fluoroquinolone antibacterials have been released for clinical use in recent
years. These new agents exhibit enhanced activity against Gram-positive organisms while …